BiotechTV - News cover image

Upstream Bio's CEO Rand Sutherland discusses today's severe asthma data for verekitug, a TSLP receptor antagonist

BiotechTV - News

00:00

Outro

Brad closes the interview with final thanks and well wishes for Upstream Bio's programs.

Play episode from 13:02
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app